Name | (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde |
---|---|
Synonyms |
Cannogenin thevetoside
Encordin Peruvosid peruvoside EINECS 214-659-9 MFCD00133752 Peruvoside from Thevetia neriifolia Cannogenin |A-L-Thevetoside |
Description | Peruvoside is a potent inhibitor of Src, PI3K, JNK, STAT, and EGFR. Peruvoside induces apoptosis and autophagy and possesses a broad spectrum of anticancer activity in breast, lung, liver cancers and leukemia. Peruvoside is a broad-spectrum and potent antiviral activity against positive-sense RNA viruses. Peruvoside sensitizes Gefitinib (HY-50895)-resistant tumour cells (A549, PC9/gef and H1975) to Gefitinib[1][2][3][4]. |
---|---|
Related Catalog | |
References |
Density | 1.31g/cm3 |
---|---|
Boiling Point | 731.6ºC at 760 mmHg |
Melting Point | 161-164ºC |
Molecular Formula | C30H44O9 |
Molecular Weight | 548.66 |
Flash Point | 236.2ºC |
Exact Mass | 548.29900 |
PSA | 131.75000 |
LogP | 2.28920 |
Vapour Pressure | 1.04E-24mmHg at 25°C |
Index of Refraction | 1.588 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | T |
---|---|
Risk Phrases | 23/24/25 |
Safety Phrases | 36/37/39-45 |
WGK Germany | 3 |
RTECS | FH4915000 |